Search

Search results

4994 results found

Outcome of Chronic Subdural Hematoma Intervention in Patients on Long-TermAntiplatelet Therapy-A Propensity Score Matched Analysis.

Salih, Mira, Michael Young, Alfonso Garcia, Martina Stippler, Efstathios Papavassiliou, Ron L Alterman, Ajith J Thomas, Philipp Taussky, Justin Moore, and Christopher S Ogilvy. 2023. “Outcome of Chronic Subdural Hematoma Intervention in Patients on Long-TermAntiplatelet Therapy-A Propensity Score Matched Analysis.”. Neurosurgery 93 (3): 586-91.

Pathway-Based Reduction of Repeat Head Computed Tomography for Patients WithComplicated Mild Traumatic Brain Injury: Implementation and Outcomes.

Stippler, Martina, Stacey Keith, Emmalin B Nelton, Charles S Parsons, Jennifer Singleton, Leslie A Bilello, Carrie D Tibbles, Roger B Davis, Jonathan A Edlow, and Carlo L Rosen. 2021. “Pathway-Based Reduction of Repeat Head Computed Tomography for Patients WithComplicated Mild Traumatic Brain Injury: Implementation and Outcomes.”. Neurosurgery 88 (4): 773-78.

Factors Associated with Extended Hospitalization in Patients Who Had Adjuvant Middle Meningeal Artery Embolization After Conventional Surgery for Chronic Subdural Hematomas.

Filo, Jean, Mira Salih, Omar Alwakaa, Felipe Ramirez Velandia, Max Shutran, Rafael A Vega, Martina Stippler, et al. 2024. “Factors Associated With Extended Hospitalization in Patients Who Had Adjuvant Middle Meningeal Artery Embolization After Conventional Surgery for Chronic Subdural Hematomas.”. World Neurosurgery.

Appointments

The Parkinson's Disease and Movement Disorders Center at BIDMC brings together an exceptional team of multidisciplinary providers to offer personalized care and the most advanced treatment to patients with Parkinson's disease, Huntington's disease, dystonia, tremors, atypical parkinsonism, and...

Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials.

Reich, Kristian, Christopher E M Griffiths, Kenneth B Gordon, Kim A Papp, Michael Song, Bruce Randazzo, Shu Li, et al. 2020. “Maintenance of Clinical Response and Consistent Safety Profile With up to 3 years of Continuous Treatment With Guselkumab: Results from the VOYAGE 1 and VOYAGE 2 Trials.”. Journal of the American Academy of Dermatology 82 (4): 936-45.